Sign in

NCT00991094Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults

Source: ClinicalTrials.gov · Last updated 12 Jun 2026

Brief summary (registry, in English)

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Status (registry)
Recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
6 Oct 2009
Start date
27 May 2005
Primary completion date
31 Dec 2027
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT00991094

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 27 May 2005 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site

Who the study is looking for

  • All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
  • Patients must sign a study-specific consent form prior to study entry

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.